FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
We are very excited to launch our new website! Please take a few moments to click around and explore...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...